Hypopharyngeal Cancer: Clinical Trials

22 trials for Hypopharyngeal Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 unknown, 6 recruiting, 5 completed, 1 active not recruiting. 9 Phase 2, 3 Not applicable, 2 Phase 1, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 29Unknown 5, Completed 2, Recruiting 2
Not applicable3Completed 2, Withdrawn 1
Phase 12Completed 1, Recruiting 1
Phase 31Unknown 1
Phase 41Active not recruiting 1

Follow Hypopharyngeal Cancer: new trials by email Literature Review of Hypopharyngeal Cancer trials Research Report on Hypopharyngeal Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
SX-682, DTX - Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma
Phase 1 / Phase 2RecruitingNational Cancer Institute (NCI)1202026-10-282026-10-23
A Machine Learning-Based Risk Prediction Model for Head and Neck Cancerous Lesions
Hypopharyngeal Cancer, Laryngeal Cancer
RecruitingThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School30002026-04-302026-09-02
Oral Mucositis Management in Patients Receiving Radiation for Head and Neck Cancer: An Evaluation of a Barrier Based Treatment
Gelclair Oral Mouth Rinse - Squamous Cell Carcinoma, Oropharyngeal Cancers
Phase 4Active not recruitingMcMaster University292025-12-152026-07-13
Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer
Surgery, Radiation, Toripalimab - Larynx Cancer, Hypopharyngeal Cancer
Phase 2RecruitingFudan University822023-08-222023-09-15
The Voice as a Tool to Detect Recurrence of Laryngeal and Hypopharyngeal Cancer
Voice recording, ENT (Ear, Nose and Throat) examination including transnasal fiberendoscopy, and VHI-30-questionnaire - Laryngeal Cancer, Hypopharyngeal Cancer
RecruitingInsel Gruppe AG, University Hospital Bern1002023-08-022025-07-29
Immune Biomarker Study for Head and Neck Cancer
Sampling - Head and Neck Cancer, Oral Cavity Cancer
RecruitingUniversity of Erlangen-Nürnberg Medical School11002022-05-162023-05-17
Efficacy and Safety of Toripalimab Combined With AP-induced Chemotherapy Followed in Non-metastatic IVB Hypopharyngeal Cancer
Cisplatin/Nedaplatin, albumin paclitaxel - Hypopharyngeal Cancer
Phase 2UnknownChinese PLA General Hospital302021-07-012024-02-20
Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal Carcinoma
Toripalimab - Laryngeal Cancer, Hypopharyngeal Cancer
Phase 2UnknownFudan University612021-04-072022-06-15
Induction Chemotherapy Combined With Camrelizumab in Locoregionally Advanced Hypopharyngeal Cancer
Camrelizumab - Hypopharyngeal Cancer, Immunotherapy
Phase 2UnknownSun Yat-sen University232020-11-012021-08-19
Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 Trial
Docetaxel, 5-fluorouracil, Cisplatin - Hypopharyngeal Cancer
Phase 3UnknownSun Yat-sen University1602020-08-012020-08-06
Acupuncture Effect on Digestion in Critically Ill Post-Operative Oral and Hypo-pharyngeal Cancer Patients
Specific acupuncture group, Metoclopramide 10mg, Non-specific acupuncture group - Oral Cancer, Hypopharyngeal Cancer
Not applicableCompletedChina Medical University Hospital282019-05-152021-03-24
Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck
BKM120, Cisplatin, Intensity-modulated radiotherapy (IMRT) - Carcinoma, Squamous Cell of Head and Neck, HPV Positive Oropharyngeal Squamous Cell Carcinoma
Phase 1CompletedDana-Farber Cancer Institute232014-09-292024-11-05
New Strategy of Improving Treatment Outcome and Larynx-preservation Rate in Locally Advanced Hypopharyngeal Carcinoma
Induction CT+ CRT group, Concurrent CRT group - Hypopharyngeal Cancer
Phase 2UnknownChinese Academy of Medical Sciences962014-09-012021-01-29
Integrated Cancer Repository for Cancer Research
Pancreatic Cancer, Thyroid Cancer
RecruitingUniversity of Nebraska9999992013-11-012026-06-29
Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer
docetaxel and cisplatin, IMRT, Nimotuzumab - Oropharyngeal Cancer, Hypopharyngeal Cancer
Phase 2UnknownThe Second People's Hospital of Sichuan802012-03-012012-03-20
A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab
Cetuximab - Oropharyngeal Cancer, Hypopharyngeal Cancer
Phase 2CompletedUniversity of Zurich682011-09-192017-11-06
Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)
neoadjuvant docetaxel/cisplatin/fluorouracil, No treatment before definitive CCRT - Hypopharyngeal Cancer
Phase 2CompletedSamsung Medical Center402010-11-012019-12-09
Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive Tract
Direct Rigid Endoscopy, Transnasal Flexible Endoscopy with Narrowband Imaging - Upper Aerodigestive Tract Lesions, Neoplasms, Oropharyngeal
Not applicableWithdrawnUniversity of California, San Francisco2010-07-012014-08-19
Robotic Assisted Surgery in Upper Aerodigestive Tract Surgery
da Vinci® Robotic System - Head and Neck Cancer, Oropharyngeal Cancer
Not applicableCompletedUniversity of Alabama at Birmingham1702007-02-012016-03-08
The Role of MMPs in the CXCL12-Induced Invasion of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma
Laryngeal Cancer, Hypopharyngeal Cancer
UnknownNational Taiwan University Hospital1002006-08-012006-03-14

Showing 20 of 22. Sign in to see all of them.

Narrower conditions

Hypopharyngeal Neoplasms (22)  ·  Laryngeal Neoplasms (12)  ·  Head and Neck Neoplasms (7)  ·  Oropharyngeal Neoplasms (7)  ·  Mouth Neoplasms (5)  ·  Nasopharyngeal Neoplasms (3)  ·  Squamous Cell Carcinoma of Head and Neck (3)  ·  Carcinoma, Squamous Cell (2)  ·  Neoplasm Metastasis (2)  ·  Paranasal Sinus Neoplasms (2)  ·  Prostatic Neoplasms (2)  ·  Salivary Gland Neoplasms (2)  ·  Adenomatous Polyposis Coli (1)  ·  Anus Neoplasms (1)  ·  Bile Duct Neoplasms (1)

Broader conditions

Neoplasms (22)  ·  Neoplasms by Site (22)  ·  Otorhinolaryngologic Diseases (22)  ·  Otorhinolaryngologic Neoplasms (22)  ·  Pharyngeal Diseases (22)  ·  Pharyngeal Neoplasms (22)  ·  Stomatognathic Diseases (22)  ·  Head and Neck Neoplasms (15)  ·  Laryngeal Diseases (12)  ·  Respiratory Tract Diseases (12)  ·  Respiratory Tract Neoplasms (12)  ·  Mouth Diseases (6)  ·  Neoplasms by Histologic Type (6)  ·  Neoplasms, Glandular and Epithelial (6)  ·  Carcinoma (4)

Interventions

Cisplatin (4)  ·  Docetaxel (3)  ·  Radiotherapy, Intensity-Modulated (2)  ·  toripalimab (2)  ·  CF regimen (1)  ·  Cetuximab (1)  ·  Fluorouracil (1)  ·  Metoclopramide (1)  ·  NVP-BKM120 (1)  ·  Narrow Band Imaging (1)  ·  Paclitaxel (1)  ·  Platinum (1)  ·  Radiation (1)  ·  Surgical Procedures, Operative (1)  ·  camrelizumab (1)

Sponsors

National Taiwan University Hospital (3)  ·  Fudan University (2)  ·  Sun Yat-sen University (2)  ·  China Medical University Hospital (1)  ·  Chinese Academy of Medical Sciences (1)  ·  Chinese PLA General Hospital (1)  ·  Dana-Farber Cancer Institute (1)  ·  Insel Gruppe AG, University Hospital Bern (1)  ·  McMaster University (1)  ·  National Cancer Institute (NCI) (1)  ·  Samsung Medical Center (1)  ·  The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (1)  ·  The Second People's Hospital of Sichuan (1)  ·  University of Alabama at Birmingham (1)  ·  University of California, San Francisco (1)

Countries

China (8)  ·  Taiwan (4)  ·  United States (4)  ·  Switzerland (2)  ·  Canada (1)  ·  Germany (1)  ·  South Korea (1)

Top investigators

Ching-Ting Tan, MD, PhD (2)  ·  Antoniu-Oreste Gostian, PD Dr. med. (1)  ·  Benjamin Frey, PD Dr.-Ing. Dr. habil. med. (1)  ·  Charalampos Floudas, M.D. (1)  ·  Ching-Ting Tan, MD,PhD (1)  ·  Glenn J. Hanna, MD (1)  ·  Junlin Yi, Professor (1)  ·  Kurt Fisher, MD, PhD (1)  ·  Manuel Weber, PD Dr. med. Dr. med. dent. (1)  ·  Mark S. Courey, MD (1)  ·  Markus Hecht, PD Dr. med. (1)  ·  Oliver Riesterer, Leitender Arzt (1)  ·  Pei-Yu Kao, M.D. (1)  ·  Roland Giger, Prof. (1)  ·  Udo Gaipl, Prof. Dr. rer. nat. habil. (1)

Results publications

PMID 19380364, PMID 19643246, PMID 20403855, PMID 31705729, PMID 33004905, PMID 36447152, PMID 42498484

NIH funding

2023 (1)